TIMOTHY FRANKLIN: Open Payments
NPI 1114586096 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,403 in 72 payments from 16 companies in 2025. Trend: 2023 $1,168 · 2024 $1,445 · 2025 $1,403
Food & beverage: $1,403
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $262 |
| Lilly USA, LLC | 13 | $164 |
| GlaxoSmithKline, LLC. | 6 | $127 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $118 |
| Novo Nordisk Inc | 6 | $107 |
| PFIZER INC. | 5 | $100 |
| Astellas Pharma US Inc | 3 | $79 |
| Amgen Inc. | 4 | $75 |
| ABBVIE INC. | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
Products named: JARDIANCE, MOUNJARO, AREXVY, FARXIGA, AIRSUPRA, Veozah, NURTEC ODT, REXULTI.
Industry payments across GA — which companies pay providers there.
